Document Detail


FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14).
MedLine Citation:
PMID:  19594619     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Fibroblast growth factor receptor 3 (FGFR3) is a proto-oncogene that is often dysregulated together with multiple myeloma SET-domain (MMSET) by the immunoglobulin heavy chain (IGH) gene in t(4;14)(pos) multiple myeloma (MM) cells, and which is usually not expressed in MM cells without this translocation. Whether FGFR3 may play a role in MM cells without t(4;14) and the IGH-MMSET fusion protein is unclear and is the focus of this report.
METHODS: FGFR3 expression was explored in cell lines with and without t(4;14) by fluorescence in situ hybridization (FISH), RT-PCR and Western Blot. FGFR3 inhibitors SU5402 and PD173074 were used to explore the role of FGFR3 in these cells.
RESULTS: We discovered an amplification of the FGFR3 locus in INA-6, a human MM cell line. We also demonstrated expression of FGFR3 mRNA and protein in the cells, probably caused by the extra copy of the gene. INA-6 cells did not have t(4;14) and neither was there any involvement of the other IG loci in translocations with the FGFR3 gene. The FGFR3 inhibitors decreased the proliferation of INA-6.
CONCLUSION: The decreased viability and proliferation in INA-6, following inhibition with FGFR3 inhibitors, indicates that FGFR3 may play a role also in cells without t(4;14) - and hence without high expression of MMSET, the ubiquitous oncoprotein in MM cells with t(4;14). This gives further credibility to the notion that FGFR3 expression is not just an epiphenomenon in t(4;14) MM, but an important part of the malignant phenotype.
Authors:
Thea K Våtsveen; Anne-Tove Brenne; Hong Y Dai; Anders Waage; Anders Sundan; Magne Børset
Related Documents :
22947449 - Biological study on carboxymethylated (1→3)-α-d-glucans from fruiting bodies of gano...
23128569 - Insl5 is a novel marker for human enteroendocrine cells of the large intestine and neur...
6091759 - Evidence that neutral sphingomyelinase of cultured murine neuroblastoma cells is orient...
22854859 - Specific capture and temperature-mediated release of cells in an aptamer-based microflu...
23453869 - Hypothermia may attenuate ischemia/reperfusion-induced cardiomyocyte death by reducing ...
21148109 - Uncovering gene regulatory networks during mouse fetal germ cell development.
20154269 - Bcl2 and casp8 regulation by nf-kappab differentially affect mitochondrial function and...
11797849 - Experimental evaluation of a cell module for hybrid liver support.
2759719 - In vitro sensitivity of immature human mast cells to chemotherapeutic agents.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-07-06
Journal Detail:
Title:  European journal of haematology     Volume:  83     ISSN:  1600-0609     ISO Abbreviation:  Eur. J. Haematol.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-14     Completed Date:  2009-11-06     Revised Date:  2012-06-05    
Medline Journal Info:
Nlm Unique ID:  8703985     Medline TA:  Eur J Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  471-6     Citation Subset:  IM    
Affiliation:
Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Olav Kyrres gt. 9, N-7489 Trondheim, Norway. thea.k.vatsveen@ntnu.no
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Line, Tumor
Cell Proliferation
Cell Survival / genetics
Chromosomes, Human, Pair 14*
Chromosomes, Human, Pair 4*
Gene Dosage / genetics
Gene Expression Regulation, Neoplastic*
Humans
In Situ Hybridization, Fluorescence
Multiple Myeloma / genetics,  metabolism*,  pathology
Quantitative Trait Loci / genetics
Receptor, Fibroblast Growth Factor, Type 3 / biosynthesis*,  genetics
Reverse Transcriptase Polymerase Chain Reaction
Translocation, Genetic*
Chemical
Reg. No./Substance:
EC 2.7.10.1/FGFR3 protein, human; EC 2.7.10.1/Receptor, Fibroblast Growth Factor, Type 3

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Analysis of telomere length in mantle cell lymphoma.
Next Document:  Chemical and electroporated transformation of Edwardsiella ictaluri using three different plasmids.